Millennium Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.1M Sell
1,906,667
-1,906,207
-50% -$17.1M 0.01% 1240
2025
Q1
$28.6M Buy
3,812,874
+3,022,769
+383% +$22.7M 0.02% 835
2024
Q4
$5.94M Sell
790,105
-532,795
-40% -$4.01M ﹤0.01% 1899
2024
Q3
$10.1M Sell
1,322,900
-428,661
-24% -$3.26M ﹤0.01% 1538
2024
Q2
$10.8M Sell
1,751,561
-78,608
-4% -$486K 0.01% 1426
2024
Q1
$9.3M Buy
1,830,169
+153,987
+9% +$782K ﹤0.01% 1550
2023
Q4
$10M Sell
1,676,182
-3,307,025
-66% -$19.8M ﹤0.01% 1470
2023
Q3
$35.3M Sell
4,983,207
-318,813
-6% -$2.26M 0.02% 632
2023
Q2
$37.3M Buy
5,302,020
+864,691
+19% +$6.09M 0.02% 661
2023
Q1
$37M Buy
4,437,329
+4,421,538
+28,000% +$36.9M 0.02% 621
2022
Q4
$181K Sell
15,791
-1,310,651
-99% -$15M ﹤0.01% 4129
2022
Q3
$16.7M Sell
1,326,442
-622,153
-32% -$7.84M 0.01% 1060
2022
Q2
$20.6M Buy
1,948,595
+1,893,640
+3,446% +$20M 0.01% 885
2022
Q1
$894K Sell
54,955
-60,879
-53% -$990K ﹤0.01% 3668
2021
Q4
$1.6M Sell
115,834
-306,019
-73% -$4.24M ﹤0.01% 3118
2021
Q3
$6.06M Sell
421,853
-293,287
-41% -$4.21M ﹤0.01% 1992
2021
Q2
$11.3M Buy
+715,140
New +$11.3M 0.01% 1278
2021
Q1
Sell
-286,632
Closed -$2.14M 4473
2020
Q4
$2.14M Sell
286,632
-3,107,280
-92% -$23.1M ﹤0.01% 2472
2020
Q3
$11.7K Sell
3,393,912
-3,171,629
-48% -$10.9K 0.01% 855
2020
Q2
$31.3M Buy
6,565,541
+113,200
+2% +$539K 0.04% 364
2020
Q1
$12.9M Sell
6,452,341
-3,488,336
-35% -$6.98M 0.03% 498
2019
Q4
$34.3M Buy
9,940,677
+2,177,342
+28% +$7.51M 0.04% 403
2019
Q3
$22.2M Buy
7,763,335
+667,038
+9% +$1.91M 0.04% 565
2019
Q2
$26.9M Buy
7,096,297
+5,539,512
+356% +$21M 0.04% 524
2019
Q1
$12.7M Buy
1,556,785
+748,758
+93% +$6.09M 0.02% 948
2018
Q4
$6.52M Sell
808,027
-371,780
-32% -$3M 0.01% 1268
2018
Q3
$9M Sell
1,179,807
-515,526
-30% -$3.93M 0.01% 1251
2018
Q2
$9.71M Sell
1,695,333
-994,922
-37% -$5.7M 0.01% 1215
2018
Q1
$12.8M Sell
2,690,255
-1,019,287
-27% -$4.86M 0.02% 1111
2017
Q4
$18.2M Sell
3,709,542
-46,623
-1% -$229K 0.03% 926
2017
Q3
$19.7M Buy
3,756,165
+350,301
+10% +$1.84M 0.03% 772
2017
Q2
$18.9M Buy
3,405,864
+567,215
+20% +$3.15M 0.03% 659
2017
Q1
$23.8M Buy
2,838,649
+2,651,655
+1,418% +$22.3M 0.04% 565
2016
Q4
$1.18M Buy
186,994
+125,838
+206% +$797K ﹤0.01% 1977
2016
Q3
$270K Buy
61,156
+31,088
+103% +$137K ﹤0.01% 2620
2016
Q2
$85K Sell
30,068
-332,221
-92% -$939K ﹤0.01% 2803
2016
Q1
$1.03M Buy
362,289
+189,037
+109% +$535K ﹤0.01% 1966
2015
Q4
$1.79M Sell
173,252
-781,636
-82% -$8.07M ﹤0.01% 1836
2015
Q3
$10.9M Sell
954,888
-962,133
-50% -$11M 0.02% 845
2015
Q2
$28.6M Sell
1,917,021
-514,102
-21% -$7.68M 0.05% 446
2015
Q1
$22M Buy
2,431,123
+2,340,855
+2,593% +$21.1M 0.04% 599
2014
Q4
$1.1M Sell
90,268
-199,846
-69% -$2.43M ﹤0.01% 2116
2014
Q3
$2.84M Buy
290,114
+141,816
+96% +$1.39M 0.01% 1466
2014
Q2
$1.89M Sell
148,298
-441,454
-75% -$5.63M 0.01% 1578
2014
Q1
$6.24M Sell
589,752
-54,003
-8% -$571K 0.02% 931
2013
Q4
$4.89M Buy
643,755
+398,163
+162% +$3.03M 0.02% 972
2013
Q3
$1.79M Buy
+245,592
New +$1.79M 0.01% 1396